Cargando…

Clinical Outcomes of People With Fabry Disease — ANZDATA Registry Study

Detalles Bibliográficos
Autores principales:	Ng, Monica S., Malacova, Eva, Hurst, Cameron, Johnson, David W., Mallett, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418971/ https://www.ncbi.nlm.nih.gov/pubmed/34514210 http://dx.doi.org/10.1016/j.ekir.2021.06.013

Ejemplares similares

Corrigendum to Ng MS, Malacova E, Hurst C, David MC, Johnson DW, Mallett AJ. “Clinical Outcomes of People With Fabry Disease — ANZDATA Registry Study.” Kidney Int Rep. 2021;6:2481–2485
por: Ng, Monica S., et al.
Publicado: (2022)

Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study
por: Wilson, Gregory J., et al.
Publicado: (2019)

End-stage kidney disease due to haemolytic uraemic syndrome – outcomes in 241 consecutive ANZDATA registry cases
por: Tang, Wen, et al.
Publicado: (2012)

Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes–an ANZDATA registry analysis
por: Pei, Juan, et al.
Publicado: (2021)

Long-term Outcomes of Single and Dual En Bloc Kidney Transplants From Small Pediatric Donors: An ANZDATA Registry Study
por: Eastment, Jacques G., et al.
Publicado: (2023)

The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)
por: Bose, Bhadran, et al.
Publicado: (2023)

The prevalence of Fabry disease in a statewide chronic kidney disease cohort – Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) study
por: Mallett, Andrew, et al.
Publicado: (2022)

Sharing genomic data from clinical testing with researchers: public survey of expectations of clinical genomic data management in Queensland, Australia
por: Vidgen, Miranda E., et al.
Publicado: (2020)

The Ckd. Qld fabRy Epidemiology (aCQuiRE) study protocol: identifying the prevalence of Fabry disease amongst patients with kidney disease in Queensland, Australia
por: Mallett, Andrew, et al.
Publicado: (2020)

Weight change trajectories in Aboriginal and Torres Strait islander Australians after kidney transplantation: a cohort analysis using the Australia and New Zealand Dialysis and Transplant registry (ANZDATA)
por: Majoni, Sandawana William, et al.
Publicado: (2019)

Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study
por: Jahan, Sadia, et al.
Publicado: (2020)

Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
por: Lenders, Malte, et al.
Publicado: (2018)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Motor involvement in Fabry disease
por: Cocozza, Sirio, et al.
Publicado: (2017)

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
por: Ortiz, Alberto, et al.
Publicado: (2016)

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2019)

Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
por: Cammisa, Marco, et al.
Publicado: (2013)

Screening for Fabry Disease in Young Strokes in the Australian Stroke Clinical Registry (AuSCR)
por: Malavera, Alejandra, et al.
Publicado: (2020)

Comment: Why are females with Fabry disease affected?
por: Beck, Michael, et al.
Publicado: (2019)

Implementation of high-throughput screening for Fabry disease in Toronto dialysis patients
por: Rasaiah, Vanessa I., et al.
Publicado: (2008)

Fabry disease previously diagnosed as Henoch-Schonlein purpura
por: Kim, Ji Hyeong, et al.
Publicado: (2015)

ERT impact on left ventricular mass in Fabry disease
por: Ortiz, Alberto
Publicado: (2019)

Are Female Patients More Overlooked in the Diagnosis of Fabry Disease?
por: Gürdoğan, Muhammet, et al.
Publicado: (2020)

Clinical and Healthcare Utilization Outcomes of Parathyroidectomy in CKD and Dialysis Patients
por: Jones, Scott A., et al.
Publicado: (2020)

An Acoustic Sensor Based on Active Fiber Fabry–Pérot Microcavities
por: Gao, Xin-Xia, et al.
Publicado: (2020)

Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2016)

Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
por: Germain, Dominique P., et al.
Publicado: (2018)

FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument
por: Shields, Alan L., et al.
Publicado: (2021)

Fabry Disease Associated With Antiglomerular Basement Membrane Disease: Chance or Consequence
por: Terinte-Balcan, George, et al.
Publicado: (2022)

Psychometric properties of the general self-efficacy scale among Thais with type 2 diabetes: a multicenter study
por: Hurst, Cameron, et al.
Publicado: (2022)

Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy
por: Fall, Brent, et al.
Publicado: (2016)

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
por: Jeyaruban, A., et al.
Publicado: (2021)

Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker
por: López-Sainz, Ángela, et al.
Publicado: (2019)

The clinical profiles of female patients with Fabry disease in Latin America: A Fabry Registry analysis of natural history data from 169 patients based on enzyme replacement therapy status
por: Martins, Ana M., et al.
Publicado: (2019)

Pain in Fabry Disease: Could Spinal Cord Stimulation be a Solution?
por: Buonanno, Pasquale, et al.
Publicado: (2023)

Clinical Case Presentation – Fabry’s Disease
Publicado: (2004)

Fabry Disease: The Current Treatment Landscape
por: Lenders, Malte, et al.
Publicado: (2021)

Cardiac abnormalities in Anderson-Fabry disease and Fabry’s cardiomyopathy
por: Morrissey, Ryan P, et al.
Publicado: (2011)

Improvement of gastrointestinal symptoms in a significant proportion of male patients with classic Fabry disease treated with agalsidase beta: A Fabry Registry analysis stratified by phenotype
por: Hopkin, Robert J., et al.
Publicado: (2020)

Fabry disease
por: Germain, Dominique P
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f8nhhpp7u5kiiuf73j89ae7ecj